Testing a new ointment for kids with plaque psoriasis
Part of Skin clinical trials.
This study tests a new ointment called RSS0393 in children and teenagers aged 6 to 17 who have plaque psoriasis. The goal is to see if the ointment is safe and how it works in the body. This may offer a new treatment option for those whose psoriasis has not cleared with other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 6 and 17 years old at the time of screening.
- You must have had plaque psoriasis for at least 3 months.
- You and a parent or guardian must agree to participate and sign a consent form.
- You must not have any other type of psoriasis or skin conditions that could affect the results.
- You must not have any active autoimmune disease other than psoriasis.
- You must not have used psoriasis creams or ointments in the last 2 weeks, or taken psoriasis pills or light therapy in the last 4 weeks, or used biologic treatments within a specific time before starting the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new ointment called RSS0393 can safely and effectively treat plaque psoriasis (a common skin condition causing red, scaly patches). You would apply it to affected skin areas and be compared to people using a placebo (inactive cream) to see if the treatment works.
This study tests a new medicine called SHR-1314 for children aged 6 to 17 with moderate to severe plaque psoriasis. The goal is to see if it safely reduces skin redness, scaling, and thickness.
This trial tests a new oral medication, CS32582, for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective at reducing skin symptoms like redness, thickness, and scaling.
This study tests a new medicine called IBI112 for teens aged 12–18 with moderate to severe plaque psoriasis. It aims to see if the medicine is safe and can help clear skin better than placebo.
This trial tests an ointment called RSS0393 for people with plaque psoriasis. It aims to see if the ointment is safe and effective in reducing psoriasis symptoms.
This trial tests how safe and how the body handles (pharmacokinetics) a psoriasis lotion called IDP-122 when used in children with plaque psoriasis. You may be able to join if your child has a suitable amount of plaque psoriasis and can follow safety rules during the study.
Hear when a new Plaque Psoriasis in Children trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.